W. Fraser

Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations

L. Riste, J. Cade, A. Heald, 2001, Diabetologia.

Epidemiology of the insulin-like growth factor system in three ethnic groups.

L. Riste, J. Cade, A. Heald, 2001, American journal of epidemiology.

Low circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) are closely associated with the presence of macrovascular disease and hypertension in type 2 diabetes.

R. Young, A. Heald, W. Taylor, 2002, Diabetes.

Cross-Sectional Analysis of Abnormalities of Mineral Homeostasis, Vitamin D and Parathyroid Hormone in a Cohort of Pre-Dialysis Patients

M. Landray, D. Wheeler, C. Baigent, 2007, Nephron Clinical Practice.

Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in noninsulin-dependent diabetes mellitus.

R. Young, M. Westwood, J. Holly, 1995, The Journal of clinical endocrinology and metabolism.

Repeated Measures of Placental Growth Factor, Placental Protein 13, and A Disintegrin and Metalloprotease 12 at First and Second Trimesters for Preeclampsia Screening

F. Audibert, E. Delvin, E. Suarthana, 2013, American Journal of Perinatology.

Influence of vitamin D supplementation on bone mineral content, bone turnover markers and fracture risk in South African schoolchildren: multicentre double-blind randomised placebo-controlled trial (ViDiKids)

L. Bekker, K. Middelkoop, L. Micklesfield, 2023, medRxiv.

SCHeLTI Platform: an Intervention Support System Tailored for a Randomized Controlled Trial (Preprint)

Jianxia Fan, N. Abdelouahab, I. Marc, 2020 .